The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 533 KB) and Technical Notes (PDF, 752 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 19.31

All Lymphoid Neoplasms With Detailed Non-Hodgkin Lymphoma Subtypesa

SEERb 5-Year Relative Survival (Percent) by Age at Diagnosis
All Races, Females, 2004-2010
Site All Ages Ages 0-19 Ages 20-64 Ages 65+
Count Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval
Low High Low High Low High Low High
Lymphoid Neoplasm 76,239 68.6 68.2 69.1 90.0 88.9 91.0 78.6 78.1 79.1 57.7 56.9 58.4
1 Hodgkin Lymphoma 6,826 86.4 85.4 87.3 96.0 94.2 97.2 91.5 90.5 92.4 52.7 48.6 56.6
2 Non-Hodgkin lymphoma 67,208 67.4 66.9 67.9 88.1 86.7 89.3 76.6 76.0 77.2 58.5 57.7 59.2
2(a) Non-Hodgkin lymphoma, B-cell 61,908 67.7 67.2 68.2 88.5 87.0 89.9 77.4 76.7 78.0 59.1 58.3 59.9
2(a) 1. Precursor Non-Hodgkin lymphoma, B-cell 3,216 67.2 65.3 69.0 88.9 87.2 90.4 35.4 31.8 39.1 11.5 7.5 16.4
2(a) 2. Mature Non-Hodgkin lymphoma, B-cell 55,792 67.7 67.2 68.3 85.6 81.2 89.0 79.0 78.3 79.6 59.3 58.5 60.1
2(a) 2.1. Chronic/Small/Prolymphocytic/ Mantle B-cell Non-Hodgkin lymphoma 11,796 78.4 77.2 79.6 - - - 88.8 87.4 90.1 73.0 71.3 74.7
2(a) 2.1.1. Chronic/Small lymphocytic leukemia/lymphoma 10,736 80.7 79.4 81.9 - - - 91.0 89.5 92.3 75.4 73.5 77.1
2(a) 2.1.2. Prolymphocytic leukemia, B-cell 45 28.4 14.1 44.6 - - - - - - 15.6 3.8 34.8
2(a) 2.1.3. Mantle-cell lymphoma 1,015 57.0 52.6 61.1 - - - 69.5 63.3 74.8 49.4 43.5 54.9
2(a) 2.2. Lymphoplasmacytic lymphoma/ Waldenstrom macroglubulinemia 1,152 76.6 72.4 80.2 - - - 85.8 80.3 89.9 71.4 65.5 76.5
2(a) 2.2.1. Lymphoplasmacytic lymphoma 547 72.0 65.4 77.5 - - - 81.5 71.7 88.1 66.9 58.1 74.3
2(a) 2.2.2. Waldenstrom macroglubulinemia 605 80.5 74.8 85.0 - - - 89.1 82.1 93.5 75.5 67.2 82.0
2(a) 2.3. Diffuse large B-cell lymphoma (DLBCL) 15,035 60.6 59.6 61.6 83.0 76.8 87.7 73.8 72.5 75.1 50.5 49.1 52.0
2(a) 2.3.1. DLBCL, NOSc 14,846 60.3 59.3 61.3 84.6 78.4 89.2 73.6 72.2 74.8 50.5 49.0 52.0
2(a) 2.3.2. Intravascular large B-cell lymphoma - - - - - - - - - - - - -
2(a) 2.3.3. Primary effusion lymphoma - - - - - - - - - - - - -
2(a) 2.3.4. Mediastinal large B-cell lymphoma 166 84.1 76.9 89.2 - - - 86.4 78.9 91.3 - - -
2(a) 2.4. Burkitt lymphoma/leukemia 589 56.8 52.2 61.2 87.9 79.2 93.2 58.7 52.3 64.5 36.3 28.0 44.6
2(a) 2.5. Marginal-zone lymphoma (MZL) 4,788 90.6 88.9 92.0 - - - 94.5 92.8 95.8 87.3 84.4 89.7
2(a) 2.5.1. Splenic MZL 403 82.5 76.1 87.4 - - - 90.4 83.1 94.6 76.3 65.2 84.3
2(a) 2.5.2. Extranodal MZL, MALTc type 2,937 94.8 92.6 96.4 - - - 96.9 94.9 98.1 92.8 88.6 95.5
2(a) 2.5.3. Nodal MZL 1,448 84.1 80.7 86.9 - - - 89.6 85.5 92.5 80.4 75.3 84.6
2(a) 2.6. Follicular lymphoma 9,089 86.7 85.6 87.8 - - - 92.2 91.1 93.2 80.3 78.2 82.3
2(a) 2.7. Hairy-cell leukemia 294 91.0 83.6 95.2 - - - 96.6 92.1 98.5 79.0 61.3 89.3
2(a) 2.8. Plasma cell neoplasms 13,043 43.3 42.1 44.4 - - - 57.9 56.1 59.6 33.6 32.1 35.1
2(a) 2.8.1. Plasmacytoma 686 59.0 53.6 63.9 - - - 75.0 68.3 80.5 42.7 35.0 50.2
2(a) 2.8.2. Multiple myeloma/ plasma-cell leukemia 12,357 42.4 41.2 43.6 - - - 56.7 54.8 58.5 33.2 31.7 34.7
2(a) 2.9. Heavy chain disease - - - - - - - - - - - - -
2(a) 3. Non-Hodgkin lymphoma, B-cell, NOSc 2,900 68.3 65.7 70.7 - - - 78.6 75.3 81.5 62.6 59.0 66.0
2(b) Non-Hodgkin lymphoma, T-cell 4,161 64.5 62.7 66.3 84.9 80.3 88.5 70.5 68.3 72.6 50.5 46.9 53.9
2(b) 1. Precursor Non-Hodgkin lymphoma, T-cell 269 61.8 55.1 67.8 88.9 81.0 93.7 47.8 37.9 57.1 14.3 3.7 31.6
2(b) 2. Mature Non-Hodgkin lymphoma, T-cell 3,851 65.2 63.2 67.0 83.3 77.2 87.8 72.2 69.9 74.3 51.7 48.1 55.2
2(b) 2.1. Mycosis fungoides/Sezary syndrome 1,017 90.6 87.2 93.1 91.4 66.2 98.1 93.4 90.1 95.7 83.8 75.1 89.7
2(b) 2.1.1. Mycosis fungoides 991 91.9 88.6 94.3 91.4 66.2 98.1 93.8 90.5 96.0 86.2 79.2 90.9
2(b) 2.1.2. Sezary syndrome 26 33.9 10.2 59.9 - - - - - - - - -
2(b) 2.2. Peripheral T-cell lymphoma 2,272 58.3 55.8 60.8 86.7 78.0 92.1 67.5 64.4 70.4 43.6 39.4 47.7
2(b) 2.2.1. Peripheral T-cell lymphoma, NOSc 743 38.0 33.9 42.1 - - - 47.6 41.7 53.4 27.4 21.9 33.2
2(b) 2.2.2. Angioimmunoblastic T-cell lymphoma 339 48.7 42.2 55.0 - - - 56.6 47.4 64.9 42.5 33.3 51.3
2(b) 2.2.3. Subcutaneous panniculitis- like T-cell lymphoma 48 61.1 41.2 76.1 - - - 59.2 32.2 78.5 - - -
2(b) 2.2.4. Anaplastic large cell lymphoma, T-cell or null-cell type 441 61.2 55.7 66.2 86.6 74.8 93.1 70.5 63.9 76.1 31.4 21.9 41.4
2(b) 2.2.5. Hepatosplenic T-cell lymphoma - - - - - - - - - - - - -
2(b) 2.2.6. Enteropathy-type T-cell lymphoma 28 26.2 11.0 44.3 - - - - - - - - -
2(b) 2.2.7. Cutaneous T-cell lymphoma, NOSc 437 81.8 75.6 86.6 - - - 87.6 81.3 91.9 72.9 60.3 82.0
2(b) 2.2.8. Primary cutaneous anaplastic large cell lymphoma 222 92.2 84.0 96.3 - - - 94.6 85.7 98.0 81.8 60.4 92.3
2(b) 2.3. Adult T-cell leukemia/lymphoma 269 47.2 40.3 53.9 78.6 67.6 86.3 32.8 23.1 42.8 25.8 14.5 38.5
2(b) 2.4. NKc/T-cell lymphoma, nasal-type/ agressive NKc-cell leukemia 143 41.6 31.6 51.3 - - - 41.2 29.8 52.3 45.3 25.3 63.3
2(b) 2.5. T-cell large granular lymphocytic leukemia 75 74.9 57.1 86.1 - - - 77.3 52.5 90.2 69.5 42.9 85.5
2(b) 2.6. Prolymphocytic leukemia, T-cell 75 22.5 11.1 36.4 - - - 28.4 13.4 45.4 19.5 6.2 38.3
2(b) 3. Non-Hodgkin lymphoma, NOSc , T-cell 41 27.3 13.4 43.2 - - - 40.2 21.1 58.6 - - -
2(c) Non-Hodgkin lymphoma, unknown lineage 1,139 59.8 56.2 63.1 88.2 83.7 91.6 61.1 54.6 66.9 42.8 37.1 48.4
2(c) 1. Precursor lymphoblastic leukemia/ lymphoma, unknown lineage 479 65.9 61.2 70.2 88.4 83.8 91.7 43.6 33.1 53.6 15.1 7.2 25.8
2(c) 2. Prolymphocytic leukemia, unknown lineage 25 60.6 36.4 78.0 - - - - - - - - -
2(c) 3. Non-Hodgkin lymphoma, NOSc, unknown lineage 635 54.4 49.2 59.4 - - - 69.0 60.8 75.9 47.8 41.2 54.1
2(*) 1. Total precursor lymphoma/leukemiad 3,964 66.7 65.1 68.4 88.9 87.4 90.2 37.7 34.5 41.0 12.4 8.8 16.6
3 Composite Hodgkin lymphoma and Non-Hodgkin lymphoma 38 46.4 25.6 64.8 - - - - - - - - -
4 Lymphoid neoplasm, NOSc 2,167 48.3 45.5 51.0 86.8 64.3 95.6 65.1 60.8 69.2 39.7 36.3 43.1

Footnotes:

a Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD.  Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110:695-708.

b SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG).

c NOS = Not otherwise specified. MALT = Mucosa-associated lymphoid tissue. NK = Natural killer.

- Statistic not displayed due to less than 25 cases.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.